Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR versus OXY PR after knee arthroplasty
2009-016957-17Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone and naloxone in postoperative pain (2 arms), sponsored by Mundipharma. Primary endpoints: 24-hour pain intensity score at rest and Average pain intensity scores at rest over 5 doses. Started Nov 2009; status: completed.
02
Drugs
oxycodonenaloxone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2009-016957-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016957-17.